NNC0247-0829
/ Novo Nordisk
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
October 28, 2022
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=103 | Completed | Sponsor: Novo Nordisk A/S | Recruiting ➔ Completed
Trial completion • Genetic Disorders • Obesity
July 12, 2021
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
(clinicaltrials.gov)
- P1; N=84; Recruiting; Sponsor: Novo Nordisk A/S; Trial completion date: May 2021 ➔ Mar 2022; Trial primary completion date: May 2021 ➔ Mar 2022
Clinical • Trial completion date • Trial primary completion date • Genetic Disorders • Obesity
September 24, 2020
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
(clinicaltrials.gov)
- P1; N=84; Recruiting; Sponsor: Novo Nordisk A/S; Trial completion date: Sep 2020 ➔ May 2021; Trial primary completion date: Sep 2020 ➔ May 2021
Clinical • Trial completion date • Trial primary completion date • Genetic Disorders • Obesity
November 05, 2019
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
(clinicaltrials.gov)
- P1; N=84; Recruiting; Sponsor: Novo Nordisk A/S; Trial completion date: Dec 2020 ➔ Sep 2020; Trial primary completion date: Dec 2020 ➔ Sep 2020
Clinical • Trial completion date • Trial primary completion date
1 to 4
Of
4
Go to page
1